u/realHarryGelb

Reddit r/stocks
· tracked since Jan 2026
Calls
1
Win Rate
0.0%
return
-94.9%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 0% Long 1 Short 0
Win Rate
7d 0%
30d 0%
90d 0%
Average Return -94.9% Long Return -94.9% Short Return -
Average Return
7d -5.0%
30d -39.8%
90d -56.5%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 16
$65.78
-94.9%
Long tiny GNPX on trial-success optionality
Author is long Genprex, a small Austin-based pre-clinical/early clinical gene therapy company developing cancer and diabetes treatments via licensing deals with MD Anderson and other institutions. The mechanism is that Genprex coordinates clinical trials, FDA relations and patents around scientists' work, and promising animal results are now transitioning to human trials. With a tiny ~$7M market cap and ~2.2M share float, even modest phase 1/phase 2 success could re-rate the company into the hundreds of millions. The author explicitly acknowledges the low probability of success as the main risk.
Other
Showing 1 of 1 calls · sorted by mentions

u/realHarryGelb has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: GNPX.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology